These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
564 related articles for article (PubMed ID: 30635067)
1. MiR-30c/PGC-1β protects against diabetic cardiomyopathy via PPARα. Yin Z; Zhao Y; He M; Li H; Fan J; Nie X; Yan M; Chen C; Wang DW Cardiovasc Diabetol; 2019 Jan; 18(1):7. PubMed ID: 30635067 [TBL] [Abstract][Full Text] [Related]
2. Inhibiting microRNA-144 abates oxidative stress and reduces apoptosis in hearts of streptozotocin-induced diabetic mice. Yu M; Liu Y; Zhang B; Shi Y; Cui L; Zhao X Cardiovasc Pathol; 2015; 24(6):375-81. PubMed ID: 26164195 [TBL] [Abstract][Full Text] [Related]
3. LAZ3 protects cardiac remodeling in diabetic cardiomyopathy via regulating miR-21/PPARa signaling. Gao L; Liu Y; Guo S; Xiao L; Wu L; Wang Z; Liang C; Yao R; Zhang Y Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3322-3338. PubMed ID: 30031228 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of miR-22 attenuates oxidative stress injury in diabetic cardiomyopathy via Sirt 1. Tang Q; Len Q; Liu Z; Wang W Cardiovasc Ther; 2018 Apr; 36(2):. PubMed ID: 29288528 [TBL] [Abstract][Full Text] [Related]
5. miR-30c Mediates Upregulation of Cdc42 and Pak1 in Diabetic Cardiomyopathy. Raut SK; Kumar A; Singh GB; Nahar U; Sharma V; Mittal A; Sharma R; Khullar M Cardiovasc Ther; 2015 Jun; 33(3):89-97. PubMed ID: 25781190 [TBL] [Abstract][Full Text] [Related]
6. MiR-20a-5p overexpression prevented diabetic cardiomyopathy via inhibition of cardiomyocyte apoptosis, hypertrophy, fibrosis and JNK/NF-κB signalling pathway. Liu X; Guo B; Zhang W; Ma B; Li Y J Biochem; 2021 Oct; 170(3):349-362. PubMed ID: 33837411 [TBL] [Abstract][Full Text] [Related]
7. Silencing of peroxisome proliferator-activated receptor-alpha alleviates myocardial injury in diabetic cardiomyopathy by downregulating 3-hydroxy-3-methylglutaryl-coenzyme A synthase 2 expression. Wang L; Bi X; Han J IUBMB Life; 2020 Sep; 72(9):1997-2009. PubMed ID: 32734614 [TBL] [Abstract][Full Text] [Related]
9. Mst1 knockdown alleviates cardiac lipotoxicity and inhibits the development of diabetic cardiomyopathy in db/db mice. Xiong Z; Li Y; Zhao Z; Zhang Y; Man W; Lin J; Dong Y; Liu L; Wang B; Wang H; Guo B; Li C; Li F; Wang H; Sun D Biochim Biophys Acta Mol Basis Dis; 2020 Aug; 1866(8):165806. PubMed ID: 32320827 [TBL] [Abstract][Full Text] [Related]
10. The Role of Heme Oxygenase 1 in the Protective Effect of Caloric Restriction against Diabetic Cardiomyopathy. Waldman M; Nudelman V; Shainberg A; Zemel R; Kornwoski R; Aravot D; Peterson SJ; Arad M; Hochhauser E Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31100876 [TBL] [Abstract][Full Text] [Related]
11. Dihydromyricetin Prevents Diabetic Cardiomyopathy via miR-34a Suppression by Activating Autophagy. Ni T; Lin N; Lu W; Sun Z; Lin H; Chi J; Guo H Cardiovasc Drugs Ther; 2020 Jun; 34(3):291-301. PubMed ID: 32212062 [TBL] [Abstract][Full Text] [Related]
12. MiR-21 protected against diabetic cardiomyopathy induced diastolic dysfunction by targeting gelsolin. Dai B; Li H; Fan J; Zhao Y; Yin Z; Nie X; Wang DW; Chen C Cardiovasc Diabetol; 2018 Sep; 17(1):123. PubMed ID: 30180843 [TBL] [Abstract][Full Text] [Related]
13. miR-340-5p Mediates Cardiomyocyte Oxidative Stress in Diabetes-Induced Cardiac Dysfunction by Targeting Mcl-1. Zhu Y; Yang X; Zhou J; Chen L; Zuo P; Chen L; Jiang L; Li T; Wang D; Xu Y; Li Q; Yan Y Oxid Med Cell Longev; 2022; 2022():3182931. PubMed ID: 35126811 [TBL] [Abstract][Full Text] [Related]
14. USP28 Serves as a Key Suppressor of Mitochondrial Morphofunctional Defects and Cardiac Dysfunction in the Diabetic Heart. Xie SY; Liu SQ; Zhang T; Shi WK; Xing Y; Fang WX; Zhang M; Chen MY; Xu SC; Fan MQ; Li LL; Zhang H; Zhao N; Zeng ZX; Chen S; Zeng XF; Deng W; Tang QZ Circulation; 2024 Feb; 149(9):684-706. PubMed ID: 37994595 [TBL] [Abstract][Full Text] [Related]
15. Growth differentiation factor 11 regulates high glucose-induced cardiomyocyte pyroptosis and diabetic cardiomyopathy by inhibiting inflammasome activation. Zhang J; Wang G; Shi Y; Liu X; Liu S; Chen W; Ning Y; Cao Y; Zhao Y; Li M Cardiovasc Diabetol; 2024 May; 23(1):160. PubMed ID: 38715043 [TBL] [Abstract][Full Text] [Related]
16. Glucagon-like peptide-1 ameliorates cardiac lipotoxicity in diabetic cardiomyopathy via the PPARα pathway. Wu L; Wang K; Wang W; Wen Z; Wang P; Liu L; Wang DW Aging Cell; 2018 Aug; 17(4):e12763. PubMed ID: 29659121 [TBL] [Abstract][Full Text] [Related]
17. Activation of nuclear β-catenin/c-Myc axis promotes oxidative stress injury in streptozotocin-induced diabetic cardiomyopathy. Liu P; Su J; Song X; Wang S Biochem Biophys Res Commun; 2017 Dec; 493(4):1573-1580. PubMed ID: 28989026 [TBL] [Abstract][Full Text] [Related]
18. Nuclear miR-320 Mediates Diabetes-Induced Cardiac Dysfunction by Activating Transcription of Fatty Acid Metabolic Genes to Cause Lipotoxicity in the Heart. Li H; Fan J; Zhao Y; Zhang X; Dai B; Zhan J; Yin Z; Nie X; Fu XD; Chen C; Wang DW Circ Res; 2019 Dec; 125(12):1106-1120. PubMed ID: 31638474 [TBL] [Abstract][Full Text] [Related]
19. An Aza resveratrol-chalcone derivative 6b protects mice against diabetic cardiomyopathy by alleviating inflammation and oxidative stress. You S; Qian J; Sun C; Zhang H; Ye S; Chen T; Xu Z; Wang J; Huang W; Liang G J Cell Mol Med; 2018 Mar; 22(3):1931-1943. PubMed ID: 29327811 [TBL] [Abstract][Full Text] [Related]
20. Si-Miao-Yong-An decoction preserves cardiac function and regulates GLC/AMPK/NF-κB and GLC/PPARα/PGC-1α pathways in diabetic mice. Li L; Chen X; Su C; Wang Q; Li R; Jiao W; Luo H; Tian Y; Tang J; Li X; Liu B; Wang W; Zhang D; Guo S Biomed Pharmacother; 2020 Dec; 132():110817. PubMed ID: 33068937 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]